Notice of Clarification of Application Instructions in PAR-14-240 "Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01)"

Notice Number: NOT-CA-15-016

Key Dates
Release Date:  March 4, 2015

Related Announcements

Issued by
National Cancer Institute (NCI)


The Purpose of this Notice is to clarify that there are additional requirements for applications to this FOA under the subheadings "Descriptive Title of Applicant's Project", "Cover Letter Attachment", and "PHS 398 Research Plan" in Part 2, Full Text of Announcement, Section IV., Application and Submission Information, 2. Content and Form of Application Submission, of PAR-14-240.

Applicants are strongly encouraged to discuss these additional requirements with staff before submitting collaborative R01 applications in response to this FOA.

The relevant sections are as follows:

Part 2. Section IV.2 Content and Form of Application Submission

SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed. The following additional
Instructions apply.

Descriptive Title of Applicant's Project: To allow NIH to identify a group of applications as a related set of collaborative R01s, the titles for each R01 in the set must have the following format:  a “1/N” indicator + Identical Title (e.g., “1/3”, where the 1/3 means this is site 1 of 3 sites in the set.  The other sites will be labeled 2/3, etc.)  Titles may not exceed 200 characters in length, including the tag, e.g., 1/3, at the beginning of the title.

Cover Letter Attachment: The Cover Letter is one pdf file only. The following collaborative information is required in the Cover Letter:  a listing of all the applications that are a part of the set of collaborative R01s being submitted, including for each: 1) the PD/PI(s) name(s), 2) the Title (including the tag, e.g., “1/3”), and 3) the Applicant Institution.  Each site should submit an identical listing.

PHS 398 Research Plan

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

The application from each site must contain a Research Strategy that clearly describes those aspects of the project that are common to all sites of the collaboration. All variations in the Research Strategy between sites, no matter how minor, should be highlighted in a subsection of the Research Strategy with the heading "Elements Unique to This Site." In this subsection, PDs/PIs should describe, for example, how the research site has a unique role in the collaboration, such as data coordination, statistical analyses, (etc).


Please direct all inquiries to:

Cheryl L. Marks, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6217